Investigation of miR-26a-5p and miR-19a-3p expression levels in angiographically confirmed coronary artery disease.
Neslihan CobanAycan Fahri ErkanAybike Sena OzuynukFatma Nihan Turhan ÇağlarPublished in: Acta cardiologica (2023)
Our findings show that miR-26a-5p expression is altered in CAD presence while miR-19a-3p expression is different in diabetes. Both miRNAs are closely related to risk factors of CAD, therefore, could be therapeutic targets for CAD treatment.